+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Advanced Wound Dressing Market Report and Forecast 2024-2032

  • PDF Icon

    Report

  • 160 Pages
  • September 2023
  • Region: Global
  • Expert Market Research
  • ID: 5895172
The advanced wound dressing market size was valued at USD 8.7 billion in 2023, driven by the emphasis on treating chronic wounds occurring due to diabetes, obesity, and age across the globe. The market is expected to grow at a CAGR of 4.3% during the forecast period of 2024-2032, with the values likely to rise to USD 12.7 billion by 2032.

Advanced Wound Dressing: Introduction

Advanced wound dressings are specialized medical products designed to aid the healing of acute and chronic wounds. These dressings are engineered to provide a conducive environment for wound healing by managing moisture, promoting tissue regeneration, and preventing infection.

Advanced wound dressings often incorporate innovative materials and technologies, including antimicrobial agents, growth factors, and smart monitoring systems, to optimize the healing process. These dressings offer superior wound care compared to traditional bandages, facilitating faster, and more effective wound recovery.

Key Trends in the Global Advanced Wound Dressing Market

The rising prevalence of chronic wounds, such as diabetic ulcers and pressure sores, is on rise due to aging populations and an increase in chronic health conditions, like diabetes and obesity. This drives the demand for advanced wound dressings designed for long-term wound management.

Advanced wound dressings incorporating innovative materials like hydrogels, foams, films, and nanomaterials are gaining popularity. These materials offer better wound healing properties, such as moisture control, antibacterial effects, and improved adherence to the wound bed.

Infection control remains a significant concern in wound care. Antimicrobial dressings, which release agents like silver ions or honey, are being used to prevent or treat wound infections.

The incorporation of smart technologies into wound dressings, such as sensors and indicators for monitoring wound status (e.g., pH, temperature, or bacterial load), gained attention. These dressings provide real-time data to healthcare providers, improving patient care.

Advances in genomics and biotechnology are paving the way for personalized wound care. Tailoring wound dressings to an individual's genetics and specific wound characteristics is becoming a possibility, potentially leading to more effective treatment outcomes.

Global Advanced Wound Dressing Market Segmentation

Market Breakup by Products

  • Infection Management
  • Exudate Management
  • Active Wound Care
  • Therapy Devices

Market Breakup by Applications

  • Chronic Wounds
  • Acute Wounds

Market Breakup by End User

  • Hospitals
  • Community Health Service Centres

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Global Advanced Wound Dressing Market Overview

The global market for advanced wound dressing has been witnessing consistent growth driven by the increasing prevalence of chronic wounds, such as diabetic ulcers and pressure sores. The rising prevalence can be attributed to factors like ageing populations and rising chronic health conditions.

Additionally, a growing awareness among healthcare providers and patients about the benefits of these dressings is playing a pivotal role in market expansion. The market is not restricted to developed regions but also growing in emerging markets as healthcare infrastructure improved and awareness increased.

Mergers and acquisitions are common in the advanced wound dressing market. Major healthcare companies are acquiring smaller manufacturers and startups to expand their product portfolios and global market reach. Such strategic moves allow companies to offer a wider range of wound care solutions and leverage synergies in research and development.

Government initiatives are also playing a role in shaping the market. Regulatory standards and approvals ensure the safety and efficacy of advanced wound dressings. Government agencies and healthcare organizations promote the use of advanced wound care products, particularly in cases of chronic wounds, through guidelines and reimbursement policies, further supporting market growth.

Global Advanced Wound Dressing Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players.

The major companies in the market are as follows:

  • 3M (Acelity Inc.)
  • Adynxx, Inc.
  • B Braun Melsungen AG
  • ConvaTec Group plc
  • Essity AB (BSN Medical GmbH)
  • Integra Lifesciences (Derma sciences)
  • Investor AB (Mölnlycke Health Care AB)
  • Johnson & Johnson
  • Medline Industries, Inc.
  • Medtronic plc
The publisher always strives to provide you with the latest information. The numbers in the article are only indicative and may be different from the actual report.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Advanced Wound Dressing Market Overview
3.1 Global Advanced Wound Dressing Market Historical Value (2017-2023)
3.2 Global Advanced Wound Dressing Market Forecast Value (2024-2032)
4 Global Advanced Wound Dressing Market Landscape
4.1 Advanced Wound Dressing: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Advanced Wound Dressing: Product Landscape
4.2.1 Analysis by Products
4.2.2 Analysis by Applications
5 Global Advanced Wound Dressing Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Advanced Wound Dressing Market Segmentation
6.1 Global Advanced Wound Dressing Market by Products
6.1.1 Market Overview
6.1.2 Infection Management
6.1.3 Exudate Management
6.1.4 Active Wound Care
6.1.5 Therapy Devices
6.2 Global Advanced Wound Dressing Market by Applications
6.2.1 Market Overview
6.2.2 Chronic Wounds
6.2.3 Acute Wounds
6.3 Global Advanced Wound Dressing Market by End User
6.3.1 Market Overview
6.3.2 Hospitals
6.3.3 Community Health Service Centres
6.4 Global Advanced Wound Dressing Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Advanced Wound Dressing Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Advanced Wound Dressing Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Advanced Wound Dressing Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Advanced Wound Dressing Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Advanced Wound Dressing Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.3 INDIA CDSCO
12.1.4 JAPAN PMDA
12.1.5 Others
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by NIH Departments
14.7 Analysis by Recipient Organization
15 Funding and Investment Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Partnership and Collaborations Analysis
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Supplier Landscape
17.1 3M (Acelity Inc.)
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Adynxx, Inc.
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 B Braun Melsungen AG
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 ConvaTec Group plc
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Essity AB (BSN Medical GmbH)
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Integra Lifesciences (Derma sciences)
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Investor AB (Mölnlycke Health Care AB)
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Johnson & Johnson
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Medline Industries, Inc.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Medtronic plc
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
18 Key Opinion Leaders (KOL) Insights (Additional Insight)
19 Company Competitiveness Analysis (Additional Insight)
19.1 Very Small Companies
19.2 Small Companies
19.3 Mid-Sized Companies
19.4 Large Companies
19.5 Very Large Companies
20 Payment Methods (Additional Insight)
20.1 Government Funded
20.2 Private Insurance
20.3 Out-of-Pocket

Companies Mentioned

  • 3M (Acelity Inc.)
  • Adynxx Inc.
  • B Braun Melsungen AG
  • ConvaTec Group plc
  • Essity AB (BSN Medical GmbH)
  • Integra Lifesciences (Derma sciences)
  • Investor AB (Mölnlycke Health Care AB)
  • Johnson & Johnson
  • Medline Industries Inc.
  • Medtronic plc

Methodology

Loading
LOADING...